Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-20 Sale |
2024-09-24 8:22 pm |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
125,092 | $28.57 | $3,573,980 | 47,894 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-03 6:30 pm |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
2,157 | $18.91 | $40,789 | 40,439 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-25 4:46 pm |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
90,000 | $15.78 | $1,419,759 | 166,082 (Direct) |
View |
| 2023-05-02 Sale |
2023-05-03 6:26 pm |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
1,336 | $8.9049 | $11,897 | 26,543 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-10-11 Exercise |
2024-10-16 4:23 pm |
2024-09-01 2030-09-01 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
70,000 | $0 | 204,026 (Direct) |
View |
| 2024-10-11 Exercise |
2024-10-16 4:23 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
70,000 | $0.71 | 204,026 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 7:21 pm |
N/A 2031-07-06 |
OnKure Therapeutics Inc. | OKUR | Carruthers R Michael Director |
23,323 | $0 | 23,323 (Direct) |
View |
| 2024-09-20 Exercise |
2024-09-24 8:22 pm |
N/A 2030-12-15 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
96,068 | $0 | 47,894 (Direct) |
View |
| 2024-09-20 Exercise |
2024-09-24 8:22 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
96,068 | $1.93 | 47,894 (Direct) |
View |
| 2024-08-12 Option Award |
2024-08-14 4:13 pm |
N/A 2034-08-12 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
161,875 | $0 | 161,875 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-17 4:16 pm |
N/A 2034-06-12 |
Elevation Oncology Inc. | ELEV | Carruthers R Michael Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2024-05-01 Exercise |
2024-05-03 6:30 pm |
N/A 2032-05-01 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
5,208 | $0 | 40,439 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-25 4:46 pm |
N/A 2030-12-15 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
90,000 | $0 | 166,082 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-25 4:46 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
90,000 | $1.93 | 166,082 (Direct) |
View |
| 2023-08-17 Option Award |
2023-08-18 7:13 pm |
N/A 2033-08-17 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-06-22 Exercise |
2023-06-26 4:28 pm |
N/A 2030-09-01 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
10,000 | $0 | 226,146 (Direct) |
View |
| 2023-06-22 Exercise |
2023-06-26 4:28 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
10,000 | $0.71 | 226,146 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 4:11 pm |
N/A 2033-06-15 |
Elevation Oncology Inc. | ELEV | Carruthers R Michael Director |
31,238 | $0 | 31,238 (Direct) |
View |
| 2023-05-01 Exercise |
2023-05-03 6:26 pm |
N/A 2032-05-01 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
5,208 | $0 | 26,543 (Direct) |
View |
| 2022-08-08 Option Award |
2022-08-10 5:42 pm |
N/A 2032-08-08 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 6:41 pm |
N/A 2032-06-16 |
Elevation Oncology Inc. | ELEV | Carruthers R Michael Director |
15,619 | $0 | 15,619 (Direct) |
View |
| 2022-05-23 Exercise |
2022-05-25 6:11 pm |
N/A 2030-09-01 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
9,000 | $0.71 | 219,122 (Direct) |
View |
| 2022-05-01 Option Award |
2022-05-03 4:14 pm |
N/A 2025-05-01 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
15,625 | $0 | 15,625 (Direct) |
View |
| 2021-08-17 Option Award |
2021-08-19 5:09 pm |
N/A 2031-08-17 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
120,000 | $0 | 120,000 (Direct) |
View |
Ownership |
2021-06-24 6:07 pm |
N/A 2031-05-06 |
Elevation Oncology Inc. | ELEV | Carruthers R Michael Director |
0 | $0 | 47,330 (Direct) |
View |
Ownership |
2021-03-25 9:34 pm |
N/A 2030-09-01 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
0 | $0 | 443,180 (Direct) |
View |